Nicholas James Haradhvala, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunotherapy, Adoptive | 4 | 2024 | 1271 | 0.780 |
Why?
|
Research Personnel | 1 | 2024 | 573 | 0.660 |
Why?
|
DNA Mismatch Repair | 2 | 2020 | 426 | 0.650 |
Why?
|
DNA Polymerase III | 1 | 2018 | 55 | 0.630 |
Why?
|
DNA Polymerase II | 1 | 2018 | 107 | 0.610 |
Why?
|
DNA Mutational Analysis | 4 | 2019 | 4183 | 0.490 |
Why?
|
Biological Products | 1 | 2022 | 859 | 0.450 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1377 | 0.430 |
Why?
|
DNA Repair | 1 | 2016 | 2045 | 0.280 |
Why?
|
DNA Damage | 1 | 2016 | 2429 | 0.270 |
Why?
|
Mutation | 8 | 2020 | 29777 | 0.250 |
Why?
|
Neoplasms | 8 | 2023 | 21675 | 0.240 |
Why?
|
Multiple Myeloma | 4 | 2022 | 5185 | 0.230 |
Why?
|
Herpesvirus 6, Human | 1 | 2023 | 95 | 0.220 |
Why?
|
Genome, Human | 5 | 2020 | 4418 | 0.220 |
Why?
|
Virus Activation | 1 | 2023 | 319 | 0.200 |
Why?
|
Virus Latency | 1 | 2023 | 358 | 0.190 |
Why?
|
Primary Myelofibrosis | 1 | 2022 | 215 | 0.180 |
Why?
|
Tristetraprolin | 1 | 2020 | 42 | 0.180 |
Why?
|
DNA Replication | 2 | 2018 | 1399 | 0.180 |
Why?
|
INDEL Mutation | 2 | 2020 | 279 | 0.180 |
Why?
|
Antigens, CD19 | 1 | 2022 | 380 | 0.180 |
Why?
|
Microsatellite Instability | 2 | 2020 | 684 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2022 | 182 | 0.170 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2020 | 177 | 0.160 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2020 | 486 | 0.150 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2020 | 436 | 0.140 |
Why?
|
Genomics | 3 | 2023 | 5714 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1836 | 0.130 |
Why?
|
Mutagenesis | 1 | 2019 | 1263 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1986 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 799 | 0.130 |
Why?
|
Databases, Genetic | 2 | 2020 | 1782 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2009 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2022 | 2942 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4386 | 0.120 |
Why?
|
Cytidine Deaminase | 1 | 2015 | 252 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1055 | 0.100 |
Why?
|
Cell Division | 1 | 2018 | 4568 | 0.100 |
Why?
|
Proteomics | 1 | 2023 | 3639 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1332 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3591 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3492 | 0.080 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 1350 | 0.080 |
Why?
|
Plasma Cells | 2 | 2022 | 593 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8430 | 0.080 |
Why?
|
Humans | 23 | 2024 | 743811 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3480 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5170 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1596 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
Roseolovirus Infections | 1 | 2023 | 45 | 0.060 |
Why?
|
Genome-Wide Association Study | 3 | 2020 | 12259 | 0.060 |
Why?
|
Splenomegaly | 1 | 2022 | 190 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7719 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2023 | 442 | 0.050 |
Why?
|
Acetylation | 1 | 2023 | 1084 | 0.050 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2020 | 44 | 0.050 |
Why?
|
DNA Breaks | 1 | 2020 | 49 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 629 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13691 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2020 | 393 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3583 | 0.040 |
Why?
|
K562 Cells | 1 | 2020 | 635 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 513 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 40545 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2018 | 195 | 0.040 |
Why?
|
Computer Graphics | 1 | 2019 | 360 | 0.040 |
Why?
|
Nitriles | 1 | 2022 | 953 | 0.040 |
Why?
|
Gene Duplication | 1 | 2018 | 328 | 0.040 |
Why?
|
Genes, myc | 1 | 2018 | 399 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 697 | 0.040 |
Why?
|
CA-125 Antigen | 1 | 2019 | 286 | 0.040 |
Why?
|
Cell Death | 1 | 2022 | 1705 | 0.030 |
Why?
|
Clone Cells | 1 | 2019 | 1692 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1356 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 376 | 0.030 |
Why?
|
Anilides | 1 | 2018 | 409 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2019 | 1097 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2018 | 671 | 0.030 |
Why?
|
Viral Load | 1 | 2023 | 3300 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2019 | 914 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 2008 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1580 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1917 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2598 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2018 | 1179 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2748 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1142 | 0.030 |
Why?
|
Bone Marrow | 1 | 2022 | 2951 | 0.030 |
Why?
|
Pyrazoles | 1 | 2022 | 1970 | 0.030 |
Why?
|
Phosphorylation | 1 | 2023 | 8436 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2779 | 0.030 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2018 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1344 | 0.020 |
Why?
|
Cell Cycle | 1 | 2020 | 2963 | 0.020 |
Why?
|
Pyrimidines | 1 | 2022 | 2945 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 1937 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1794 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1079 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2914 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2575 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.020 |
Why?
|
Base Sequence | 1 | 2020 | 12798 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2018 | 2471 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1900 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4422 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2177 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 7908 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4848 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7324 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4437 | 0.020 |
Why?
|
Pyridines | 1 | 2018 | 2827 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13273 | 0.020 |
Why?
|
Software | 1 | 2019 | 4440 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10179 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15993 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12944 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 19232 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81154 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
Female | 2 | 2019 | 380020 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 13028 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7880 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5532 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21824 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16361 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15518 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168660 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8655 | 0.010 |
Why?
|
Male | 2 | 2019 | 349776 | 0.010 |
Why?
|
Aged | 1 | 2018 | 163178 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 213241 | 0.000 |
Why?
|